Chicago Atlantic Managing Partner Peter Sack Says Trump's Endorsement Rescheduling It Became An If Not When
Portfolio Pulse from Benzinga Newsdesk
Chicago Atlantic Managing Partner Peter Sack discusses the impact of Trump's endorsement on cannabis rescheduling, indicating it's a matter of 'when' rather than 'if'. This could have implications for cannabis-related stocks and ETFs.
October 08, 2024 | 3:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The potential rescheduling of cannabis, endorsed by Trump, could positively impact the AdvisorShares Pure US Cannabis ETF (MSOS) as it may lead to regulatory changes benefiting cannabis companies.
Trump's endorsement suggests a shift in cannabis regulation, which could benefit cannabis-focused ETFs like MSOS by improving the business environment for underlying holdings.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80